FDA-Drug2026-08-19Class IIPROCESSING DEFECT
Apollo Care semaglutide injection recalled for particulate matter contamination
What this means
Apollo Care's semaglutide 5mg injection vials contain particulate matter identified as nylon/polyamide and silk/proteinaceous material. This contamination affects one lot (AC-017272, expiring 12/12/2026) of approximately 250 vials distributed nationwide. No injuries have been reported.
- Check your semaglutide vial for lot number AC-017272.
- Do not use vials from this lot; contact your pharmacy or healthcare provider for a replacement.
- If you have already injected from an affected vial, contact your doctor.
The agency's original wording
Hazard
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the U.S
Affected count
250 vials.
Manufactured in
3801 Mojave Ct Ste 101, Columbia, MO, United States
Products
SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0754-2026More Apollo Care recalls
- FDA-Drug2026-08-19Apollo Care semaglutide injection recalled for particulate matter contamination
- FDA-Drug2026-08-19Apollo Care semaglutide injection recalled for particulate contamination
- FDA-Drug2026-08-19Apollo Care semaglutide injection recalled for particulate matter contamination
- FDA-Drug2026-08-19Apollo Care semaglutide injection recalled for particulate matter contamination
- FDA-Drug2026-08-19Apollo Care semaglutide 0.9mg injection recalled for particulate matter contamination
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.